1-3 of 3
Nikola Hagedorn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Very Early/Early Relapses of ALL Show Unexpected Changes of Clonal Markers and High Heterogeneity in Initial and Relapse Treatment Response: ALL-BFM 2000 and ALL-REZ BFM 96/2002 .

Cornelia Eckert, Rolf Koehler, Thomas Flohr, Nikola Hagedorn, Anja Moericke, Martin Stanulla, Renate Kirschner-Schwabe, Gunnar Cario, Arend von Stackelberg, Claus R Bartram, Guenter Henze, Martin Schrappe, Andre Schrauder
Journal: Blood
Blood (2009) 114 (22): 2612.
https://doi.org/10.1182/blood.V114.22.2612.2612
Published: 2009
Journal Articles

Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002

Cornelia Eckert, PhD, Arend Stackelberg, MD, Nikola Hagedorn, Andrea Barth, Karl Seeger, MD, PhD, Guenter Henze, MD
Journal: Blood
Blood (2008) 112 (11): 2515.
https://doi.org/10.1182/blood.V112.11.2515.2515
Published: 2008
Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert
Journal: Blood
Blood (2007) 110 (12): 4022–4029.
https://doi.org/10.1182/blood-2007-04-082040
Published: 2007
Includes: Supplemental data